DexCom

Current Health help healthcare reduces risk & cost by monitoring, managing, and engaging patients at home.

Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet. The iLet Bionic Pancreas System was granted breakthrough designation in all configurations (insulin-only, glucagon-only, and bihormonal), including use with Zealand Pharma’s dasiglucagon, a glucagon analogue with a stability profile in a ready-to-use aqueous solution. It also offers a bionic pancreas device for glucose metabolism to the diabetes community.

TypeZero is leveraging more than 10 years of clinical trials, research, and innovation to develop the inControl Diabetes Management Platform to improve and simplify the lives of people with diabetes.

Nintamed is a distribution company with presence in Germany, Switzerland and Austria.

SweetSpot is a health data company focused on improving the use of data in the treatment of diabetes. We specialize in turning raw output from patient devices into reports that are powerful for researchers, health care providers, and patients. In clinics or from home SweetSpot performs all data extraction and analysis, relieving frustration with multiple interfaces, drivers and data formats. Our goal is to help clinics make the most of their time and their patient’s data.